Clinical trial
Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg…
NCT00288392 · Biotec Pharmacon ASA, Industry · Completed
Key facts
| NCT number | NCT00288392 |
|---|---|
| Title | Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients |
| Official title | A Double-Blind Therapeutic Exploratory Clinical Study to Evaluate the Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients |
| Lead sponsor | Biotec Pharmacon ASA, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Foot Ulcer |
| Intervention type | Drug |
| Interventions | Soluble beta-1, 3/1, 6-glucan |
| Enrollment | 60 |
| Start date | Jun 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Feb 8, 2006 |
| Last update posted | Oct 18, 2006 |
| Countries | Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: